SCHEMBL7815467

SCHEMBL7815467

BrCCC=C1c2ccccc2-c2ccccc2-c2ccccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 6/20 0.41
CYP3A4 P08684 5/20 0.41
RET P07949 4/20 0.41
CYP2C19 P33261 2/20 0.41
SLC6A2 P23975 8/20 0.40
HRH1 P35367 8/20 0.40
CHRM1 P11229 7/20 0.40
HTR2B P41595 7/20 0.40
KCNH2 Q12809 7/20 0.40
LMNA P02545 6/20 0.40
CYP2D6 P10635 6/20 0.40
CHRM2 P08172 6/20 0.40
DRD2 P14416 6/20 0.40
ADRA2C P18825 6/20 0.40
CHRM3 P20309 6/20 0.40
HTR2A P28223 6/20 0.40
HTR2C P28335 6/20 0.40
SLC6A4 P31645 6/20 0.40
ADRA1A P35348 6/20 0.40
DRD3 P35462 6/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL654406 0.83 LMNA (0.61) CYP1A2CYP3A4RETCYP2C19SLC6A2
SCHEMBL15908322 0.81 CYP3A4 (0.50) CYP1A2CYP3A4RETCYP2C19SLC6A2
SCHEMBL8185708 0.81 HTR2B (0.42) CYP1A2CYP3A4RETCYP2C19SLC6A2
SCHEMBL8185372 0.81 SIGMAR1 (0.50) CYP1A2CYP3A4CYP2C19SLC6A2HRH1
SCHEMBL653565 0.81 CYP3A4 (0.63) CYP1A2CYP3A4RETCYP2C19SLC6A2
SCHEMBL656251 0.77 LTK (0.49) RETLMNANTRK1NPC1HTT
SCHEMBL2858563 0.77 BCHE (0.44) CYP1A2CYP3A4RETCYP2C19SLC6A2
SCHEMBL656250 0.77 LTK (0.49) RETLMNANTRK1NPC1HTT
SCHEMBL2878604 0.77 BCHE (0.44) CYP1A2CYP3A4RETCYP2C19SLC6A2
SCHEMBL6968239 0.77 HTR2B (0.49) CYP1A2CYP3A4RETCYP2C19SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0869954-B1 HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF NEUROGENIC INFLAMMATION NOVO NORDISK AS (DK) 2001-09-19 EP disclosed
EP-0869954-A1 NOVEL HETEROCYCLIC COMPOUNDS NOVO NORDISK A/S (DK) 1998-10-14 EP disclosed
WO-1996031499-A1 NOVEL HETEROCYCLIC COMPOUNDS NOVO NORDISK A/S (DK) 1996-10-10 WO disclosed